30.08.2022Magdalini Polymenidou granted a Target ALS and Alzheimer’s Drug Discovery Foundation Award for Biomarker Research

We congratulate Prof. Dr. Magdalini Polymenidou and her lab for receiving the Target ALS and Alzheimer’s Drug Discovery Foundation Award for Biomarker Research, for their collaborative project with the University of Verona and Trieste International School for Advanced Studies. The consortium will work towards the development of a diagnostic test for TDP-43 proteinopathies using nasal swabs.

Magdalini Polymenidou awarded Target ALS and Alzheimer’s Drug Discovery Foundation Award

Back to news overview

Unterseiten

Support of applicants for the SNSF Professorial Fellowship / SNSF Starting Grant in the field of "Quantitative Biomedicine"
The Krauthammer Group Develops Explainable Deep Learning Model for Predicting Disease Activity in Joint Disorders
The Krauthammer group and collaborators develop advanced AI model to predict disease risk from multimodal data
In collaboration, the Joller group and the Krauthammer group reveal the regulatory role of tissue-specific Tregs in autoimmune diseases

Department of Quantitative Biomedicine

Quicklinks und Sprachwechsel

Main navigation

30.08.2022Magdalini Polymenidou granted a Target ALS and Alzheimer’s Drug Discovery Foundation Award for Biomarker Research

Unterseiten